When it comes to healthcare and MedTech, Europe is the place bursting with innovations and other solutions to help us live healthier and longer lives. On top of that, it presents a huge opportunity for startups since the size and potential of the market are nearly unrivaled. Lots and lots of investors are investing money on numerous MedTech startups that promises to change everything in health care sector.
Secured € 15 million
Citryll announced today the first closing of a targeted € 15 million investment round, funded by ModiQuest B.V., BOM Brabant Ventures, BrightGene, and Curie Capital. The proceeds will be used to progress the pre-clinical and clinical development of Citryll’s tACPA antibodies, inhibitors of neutrophil extracellular traps (NETs) and their formation (NETosis).
tACPA interferes with the formation, function and clearance of NETs, but downstream of the peptidylarginine deiminase (PAD) dependant citrullination pathway. It does so by binding to N-terminal citrullinated epitopes in histones that are essential for NET formation.
CEO Helmuth van Es, said: